What is medCPU?
medCPU operates at the intersection of consumer technology benchmarking and enterprise healthcare solutions. The firm provides a comprehensive platform for reviewing and evaluating laptops, tablets, and 2-in-1 devices, offering data-driven insights that cater to a broad demographic of professionals, students, and gamers. Beyond its consumer-facing hardware analysis, medCPU leverages over a decade of specialized experience in healthcare technology, applying rigorous analytical frameworks to improve clinical decision-making and operational efficiency. This unique market position allows the company to bridge the gap between high-end hardware performance and the critical, high-stakes requirements of the medical industry, establishing itself as a versatile entity in the modern tech ecosystem.
How much funding has medCPU raised?
medCPU has raised a total of $48.6M across 4 funding rounds:
Series A
$1.3M
Series B
$9.3M
Debt
$3M
Other Financing Round
$35M
Series A (2011): $1.3M, investors not publicly disclosed
Series B (2014): $9.3M led by New Richmond Ventures and Easton Capital Partners
Debt (2015): $3M supported by Silicon Valley Bank
Other Financing Round (2016): $35M featuring UPMC and Merck Global Health Innovation Fund
Key Investors in medCPU
UPMC
A world-renowned health care provider and insurer that integrates clinical care with research and innovation to drive advancements in medical technology.
Merck Global Health Innovation Fund
The strategic investment arm of Merck & Co., focusing on innovative healthcare solutions, digital health, and transformative medical technologies.
New Richmond Ventures
A venture capital firm dedicated to advancing entrepreneurial ecosystems by providing growth capital and strategic counsel to high-potential, scaling businesses.
What's next for medCPU?
With the recent influx of capital, medCPU is positioned to accelerate its strategic roadmap, focusing on the integration of advanced analytics into its benchmarking suite and the expansion of its healthcare technology portfolio. The company is expected to prioritize the development of proprietary algorithms that enhance the precision of its hardware reviews, while simultaneously scaling its enterprise-level health solutions to meet the growing demand for digital transformation in clinical environments. By leveraging its established reputation and the support of its diverse investor base, medCPU is well-equipped to navigate the complexities of the current market, driving innovation in both the consumer electronics and healthcare sectors through sustained investment in research and development.
See full medCPU company page
